blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2127673

EP2127673 - PHARMACEUTICAL AGENT FOR PREVENTION AND TREATMENT OF SKIN DISEASE INDUCED BY ACCELERATED KERATINIZATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.02.2013
Database last updated on 26.04.2025
Most recent event   Tooltip22.02.2013Application deemed to be withdrawnpublished on 27.03.2013  [2013/13]
Applicant(s)For all designated states
Kyoto University
36-1 Yoshida-honmachi Sakyo-ku Kyoto-shi
Kyoto 606-8501 / JP
[2009/49]
Inventor(s)01 / TAKAHASHI, Kenzo
c/o Graduate School of Medicine KYOTO UNIVERSITY Yoshida-konoecho Sakyo-ku
Kyoto-shi Kyoto 606-8501 / JP
 [2009/49]
Representative(s)polypatent
An den Gärten 7
51491 Overath / DE
[N/P]
Former [2012/02]Polypatent
An den Gärten 7
51491 Overath / DE
Former [2010/01]Polypatent
Postfach 40 02 43
51410 Bergisch Gladbach / DE
Former [2009/49]Polypatent
Braunsberger Feld 29
51429 Bergisch Gladbach / DE
Application number, filing date08720365.907.03.2008
[2009/49]
WO2008JP00479
Priority number, dateJP2007005951909.03.2007         Original published format: JP 2007059519
[2009/49]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008111296
Date:18.09.2008
Language:JA
[2008/38]
Type: A1 Application with search report 
No.:EP2127673
Date:02.12.2009
Language:EN
[2009/49]
Search report(s)International search report - published on:JP18.09.2008
(Supplementary) European search report - dispatched on:EP01.04.2010
ClassificationIPC:A61K45/00, A61K31/231, A61P17/12, A61P29/00
[2009/49]
CPC:
A61K45/06 (EP,US); A61K31/231 (EP,US); A61P17/00 (EP);
A61P17/12 (EP); A61P29/00 (EP)
C-Set:
A61K31/231, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/49]
TitleGerman:PHARMAZEUTISCHES MITTEL ZUR PRÄVENTION UND BEHANDLUNG VON HAUTERKRANKUNGEN DURCH BESCHLEUNIGTE KERATINISIERUNG[2009/49]
English:PHARMACEUTICAL AGENT FOR PREVENTION AND TREATMENT OF SKIN DISEASE INDUCED BY ACCELERATED KERATINIZATION[2009/49]
French:AGENT PHARMACEUTIQUE POUR LA PRÉVENTION ET LE TRAITEMENT D'UNE MALADIE CUTANÉE INDUITE PAR UNE KÉRATINISATION ACCÉLÉRÉE[2009/49]
Entry into regional phase18.09.2009Translation filed 
18.09.2009National basic fee paid 
18.09.2009Search fee paid 
18.09.2009Designation fee(s) paid 
18.09.2009Examination fee paid 
Examination procedure18.09.2009Examination requested  [2009/49]
28.05.2010Amendment by applicant (claims and/or description)
29.06.2010Despatch of a communication from the examining division (Time limit: M04)
10.07.2010Reply to a communication from the examining division
21.12.2010Despatch of a communication from the examining division (Time limit: M02)
04.02.2011Reply to a communication from the examining division
11.08.2011Despatch of a communication from the examining division (Time limit: M04)
10.12.2011Reply to a communication from the examining division
02.10.2012Application deemed to be withdrawn, date of legal effect  [2013/13]
07.11.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/13]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.06.2010
Fees paidRenewal fee
15.03.2010Renewal fee patent year 03
15.03.2011Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.201205   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[L]US2004209959  (HOGESTATT EDWARD [SE], et al) [L] 1-5 * paragraph [0005] - paragraph [0006] *;
 [E]WO2009012221  (UNIV TEXAS, et al) [E] 1-3 * paragraph [0157] * * paragraph [0007] *
 [I]  - MACCARRONE MAURO ET AL, "The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 5 SEP 2003, (20030905), vol. 278, no. 36, ISSN 0021-9258, pages 33896 - 33903, XP002574127 [I] 1-5 * abstract * * page 33896, column 1, line 3rd from bottom - page 33897, column 1, line 14 * * page 33902, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1074/JBC.M303994200
by applicantJPH05345722
 JPH11500411
 JP2000256323
 WO0119807
 JP2001516361
 WO0210135
 WO02053543
 JP2003201250
 WO03075908
 WO2004091521
 JP2006160644
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.